Kazuki Oishi Selected Research

Glycosphingolipids

1/2021

Host lactosylceramide enhances Edwardsiella tarda infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuki Oishi Research Topics

Disease

3	Infections 01/2021 - 11/2015
2	Neoplasms (Cancer) 02/2023 - 07/2016
1	Breast Neoplasms (Breast Cancer) 02/2023
1	Hepatocellular Carcinoma (Hepatoma) 02/2023
1	Esophageal Squamous Cell Carcinoma 02/2023
1	Esophageal Neoplasms (Esophageal Cancer) 02/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2022
1	Rheumatoid Arthritis 12/2017
1	Arthritis (Polyarthritis) 12/2017
1	Neuraminidase deficiency with beta-galactosidase deficiency 01/2016
1	Mucolipidoses (Sialidosis) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2015

Drug/Important Bio-Agent (IBA)

3	Neuraminidase (Sialidase)IBA 11/2019 - 11/2015
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2019 - 11/2015
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 02/2023
1	CateninsIBA 02/2023
1	AlloysIBA 10/2022
1	TitaniumIBA 10/2022
1	titanium alloy (TiAl6V4)IBA 10/2022
1	Glucosylceramides (Glucocerebrosides)IBA 01/2021
1	CDw17 antigen (lactosylceramide)IBA 01/2021
1	CyclodextrinsIBA 01/2021
1	GlycosphingolipidsIBA 01/2021
1	LipidsIBA 01/2021
1	stage-specific embryonic antigen-3 (GL-X)IBA 12/2017
1	CollagenIBA 12/2017
1	Antirheumatic Agents (DMARD)IBA 12/2017
1	GlycolipidsIBA 07/2016
1	GangliosidesIBA 07/2016
1	G(M3) GangliosideIBA 07/2016
1	naringinIBA 07/2016
1	GlycoconjugatesIBA 07/2016
1	Glycoproteins (Glycoprotein)IBA 11/2015
1	Mannose (D-Mannose)IBA 11/2015